about
The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.Effects of Antibiotics on Gut Microbiota.Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute CholangitisAttenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytesIntestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitisDrug monitoring in inflammatory bowel disease: helpful or dispensable?Risk factors and outcome of bacterial infections in cirrhosisMedical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications.Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients.Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response.Recruitment mechanisms of primary and malignant B cells to the human liver.Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis.[Acute-on-chronic liver failure - new Definition of a complex clinical picture].Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver.CMV infection of human sinusoidal endothelium regulates hepatic T cell recruitment and activation.External ventricular drain infections: risk factors and outcome.Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine LiverReticulocyte count and hemoglobin concentration predict survival in candidates for liver transplantation.Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.Cholestatic hepatitis, acute acalculous cholecystitis, and hemolytic anemia: primary Epstein-Barr virus infection under azathioprine.Risk factors for QT interval prolongation owing to acute gastrointestinal haemorrhage in patients with cirrhosis.Calcineurin inhibitors or anti-TNF-α agents in severe ulcerative colitis: available options and limitations.Hepatocellular carcinoma surveillance in hepatitis B virus-infected individuals: Who and how?Etiologies and outcomes of acute liver failure in Germany.[Empirical antibiotic therapy in intra-abdomial infections: cases and evidence-based therapeutic recommendations].Fungal Infections in Patients With Infected Pancreatic Necrosis and Pseudocysts: Risk Factors and Outcome.Motivation of patients with inflammatory bowel disease to participate in a clinical trial.Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history.Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.Letter: serum vitamin D levels in primary biliary cirrhosis.Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13.Microbial spectrum of intra-abdominal abscesses in perforating Crohn's disease: Results from a prospective German Registry.Letter: the therapeutic potential of targeting CCL25/CCR9 in colonic inflammatory bowel disease - reading between the lines.[Spontaneous and secondary bacterial peritonitis in cirrhotic patients with ascites].Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure.
P50
Q35177083-3F55204C-CAFC-4B0E-9173-8CA6B52375F5Q35966499-A64D3D4F-6F43-45D7-8E3E-8B028A760571Q35974264-E5BEA7D6-0E89-4179-B99C-D50BA5DBEACEQ36246303-EE804100-B155-4FE0-A450-01B042963269Q36687405-5F3D0398-F531-4549-B161-60E61C5A0F54Q36715515-7C1D96AA-81BF-4BC4-9B59-46A4221B36E1Q37127058-C9C2CAF2-8160-4D48-969C-561E4BB69C09Q37604786-D28C0DEB-9D9F-42D6-B88A-71F07DC8BE86Q37629681-7CB54227-4FED-4560-9F6D-B0E08199DB5AQ37875963-D0219857-CD84-4302-9374-9C920D6E7FA3Q38340865-3F4B0FF9-C511-4D0E-AF58-0247C5A92BD0Q38619392-B2EF635C-AA97-4C52-A208-C84550B9F7B1Q39248750-7C4ACD08-C63D-423F-8E24-DBB3194A0C1DQ39363836-B9A39107-90AF-4423-858E-FA24D2CD85D5Q39534358-616ABBFF-06CE-4254-92A1-BF35329F8E18Q40595042-2A311D7B-210A-4974-BC89-7461A60BC2ABQ40648432-17C648B7-4E43-4083-A055-BBA79E565439Q40949296-BF457F8C-2B71-4F2C-835C-85D0C53E6A52Q41431669-5EE3EC63-271A-43D3-B4B1-4462C3A6ACB7Q41611407-DB948BDC-FD87-46C1-B5A1-43CA3BCF2E16Q41993606-D2DF7680-E9CD-433D-BCB1-B54BE5A2465FQ42228173-7F7B01EF-219F-4144-BDAB-2C0270B1273FQ43770717-5888DD3B-4265-4581-8187-9E0B4DB80960Q44375853-946288F5-561B-44F1-988E-E200BBFA0C60Q44973626-05EFC253-A0E7-44F2-AF65-D468D6467405Q45263527-2F5D95D2-A403-426B-ACCE-E205AE6BFC53Q45341848-B42A580F-3A33-4D69-BF1B-EA2D058C278AQ45360969-FDBB488B-AF71-419B-B889-E393E59393C1Q46075565-8313AA74-3E74-4624-9FF6-D8FFD88404BDQ46246085-86BC2CD9-D226-4EBC-839B-A0D4A9EE2258Q47386185-E6FA12C4-1B20-4DD8-B89E-38E692116126Q47567609-723D616A-E8EB-4D75-AF8F-94ED34EEE1C0Q47787189-512B5A81-DA92-4364-BF55-EAA1423B206BQ48151065-8B67F3C1-E920-4269-AE25-7EAA7A6BC37FQ48316242-7DEC1CB9-8234-464D-9316-AF27E1EE043CQ48355456-CE5767B0-EE39-4B4F-9B3A-3611C1636B66Q50132864-8DBDB4D6-718F-4C9A-935B-494A30444ED8Q51665478-07E2CFD3-C6C1-4DD9-AE59-B7BCF9D5EA12Q53187311-3A76BA41-33D4-4E31-AD87-2C551B107EB5Q54220908-DB9F5F96-4CAB-46DF-86DD-7A386F49603B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tony Bruns
@ast
Tony Bruns
@en
Tony Bruns
@es
Tony Bruns
@nl
Tony Bruns
@sl
type
label
Tony Bruns
@ast
Tony Bruns
@en
Tony Bruns
@es
Tony Bruns
@nl
Tony Bruns
@sl
prefLabel
Tony Bruns
@ast
Tony Bruns
@en
Tony Bruns
@es
Tony Bruns
@nl
Tony Bruns
@sl
P108
P214
P1053
C-5720-2011
P106
P108
P214
P31
P496
0000-0002-5576-6914
P7859
viaf-6101018